Nanovibronix Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 154/209 in the Healthcare Equipment & Supplies industry.Institutional ownership is high.In the medium term, the stock price is expected to trend down.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Nanovibronix Inc's Score
Industry at a Glance
Industry Ranking
154 / 209
Overall Ranking
463 / 4593
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Nanovibronix Inc Highlights
StrengthsRisks
NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 240.16% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 2.56M.
Overvalued
The company’s latest PE is -0.08, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 5.95K shares, increasing 28.25% quarter-over-quarter.
NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
Ticker SymbolNAOV
CompanyNanovibronix Inc
CEOBesser (Doron)
Websitehttps://nanovibronix.com/
FAQs
What is the current price of Nanovibronix Inc (NAOV)?
The current price of Nanovibronix Inc (NAOV) is 4.020.
What is the symbol of Nanovibronix Inc?
The ticker symbol of Nanovibronix Inc is NAOV.
What is the 52-week high of Nanovibronix Inc?
The 52-week high of Nanovibronix Inc is 162.500.
What is the 52-week low of Nanovibronix Inc?
The 52-week low of Nanovibronix Inc is 3.550.
What is the market capitalization of Nanovibronix Inc?
The market capitalization of Nanovibronix Inc is 4.06M.
What is the net income of Nanovibronix Inc?
The net income of Nanovibronix Inc is -3.71M.
Is Nanovibronix Inc (NAOV) currently rated as Buy, Hold, or Sell?
According to analysts, Nanovibronix Inc (NAOV) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Nanovibronix Inc (NAOV)?
The Earnings Per Share (EPS TTM) of Nanovibronix Inc (NAOV) is -51.786.